Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.

You have to file a claim by next month to receive a payment from AT&T's $177 million privacy settlement. Peter is a writer and editor for the CNET How-To team. He has ...